Roberto Caporali

机构：University of Milan, Istituto Ortopedico Gaetano Pini · ORCID：0000-0001-6331-8559

发表论文 9 篇 · 总被引 69 次 · h-index 6

代表论文

• What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes? (2024 · Therapeutic Advances in Musculoskeletal Disease · 被引 27)
• Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study (2024 · Lara D. Veeken · 被引 11)
• Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry (2020 · Archives of Rheumatology · 被引 8)
• T H 17 cells converted into exT H 17 cells sustain rheumatoid-like IL-17–independent inflammatory arthritis (2025 · Science Immunology · 被引 6)
• Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study (2024 · RMD Open · 被引 6)
• Disease activity and disease-related factors are drivers of patient global assessment in rheumatoid arthritis: a real-life cross-sectional study (2023 · Rheumatology International · 被引 6)